| Breakdown | Oct 2025 | Oct 2024 | Oct 2023 | Oct 2022 | Oct 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 281.34M | 169.77M | 289.24M | 202.91M | 188.51M |
| Gross Profit | 20.45M | -5.01M | 12.99M | 12.09M | -1.05M |
| EBITDA | 42.60M | -6.89M | 5.62M | -1.13M | -4.18M |
| Net Income | 35.71M | -8.48M | 3.40M | -166.00K | -4.68M |
Balance Sheet | |||||
| Total Assets | 257.29M | 158.40M | 180.02M | 177.35M | 148.96M |
| Cash, Cash Equivalents and Short-Term Investments | 80.24M | 46.81M | 48.17M | 26.52M | 32.34M |
| Total Debt | 13.04M | 14.53M | 18.48M | 19.56M | 12.03M |
| Total Liabilities | 132.86M | 82.59M | 92.50M | 92.94M | 64.12M |
| Stockholders Equity | 111.80M | 75.81M | 87.95M | 84.55M | 84.72M |
Cash Flow | |||||
| Free Cash Flow | 36.95M | 5.59M | 24.49M | -20.33M | -28.66M |
| Operating Cash Flow | 39.21M | 7.41M | 31.34M | -12.81M | -22.25M |
| Investing Cash Flow | -3.39M | -1.79M | -8.90M | -1.60M | -4.58M |
| Financing Cash Flow | -615.99K | -7.17M | -1.09M | 7.53M | -5.36M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | HK$353.76M | 1.86 | 16.37% | ― | 20.41% | 188.08% | |
72 Outperform | HK$324.80M | 1.13 | 32.61% | ― | -3.44% | 1060.87% | |
71 Outperform | HK$155.94M | 3.77 | 10.87% | 23.73% | -32.31% | -51.89% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
63 Neutral | HK$22.18B | 659.69 | 1.29% | ― | 78.48% | -33.33% | |
53 Neutral | HK$120.61M | 10.08 | 2.70% | ― | -27.58% | -18.28% | |
41 Neutral | HK$129.61M | -36.13 | -0.68% | 7.69% | -33.92% | -94.74% |